Does Fridays GLP-1 Work? It Depends Which of Their 8 Paths You Buy

Disclosure: The RX Index may earn a commission if you use a marked link on this page. It costs you nothing extra, and it did not change a single finding below — including the pricing problem, the refund limits, and the complaint record we found.

Does Fridays GLP-1 work? Yes — but the answer changes by path. Wegovy and Zepbound have product-specific FDA review and trials. Fridays does not publish a trial of its finished compounded semaglutide or tirzepatide products. And two of its eight paths are not built for primary weight loss.

But here's the part almost nobody catches.

Fridays displays eight GLP-1 paths, not one. Six appear across its weight-loss and pricing pages. Two are microdose paths that Fridays says are outside a primary weight-loss goal.

One microdose path costs $198 a month. The standard month-to-month weight-loss version of tirzepatide costs $359. But Fridays' current pricing page also shows a temporary $198 promotion for weight-loss tirzepatide.

Same $198 headline. Same website. Different path.

So a person shopping on price can pick the cheaper one and end up on a plan the company itself says isn't built for the thing they want. Or they can see $198 and still not know which tirzepatide path they are buying.

That's what this page is for. We're going to show you all eight paths in one table, tell you which one matches your goal, and show you exactly what the evidence behind it does and doesn't prove.

Does Fridays GLP-1 work? The 8 paths side by side

We pulled every distinct GLP-1 path Fridays displayed across its weight-loss, pricing, and microdosing pages on August 29, 2026. They live on separate pages and do not all use the same pricing model, which is why most people never see them together.

Source: Fridays' weight-loss page, pricing page, and microdosing page, all loaded August 29, 2026. Fridays notes that prices can change and promotional codes may apply. We did not submit a medical intake, so we could not verify the final checkout total behind the promotional numbers.

The same pricing cards also render $279/mo with an annual plan for semaglutide and $389/mo with an annual plan for tirzepatide. Those figures do not reconcile with the $150 and $240 annual rates shown elsewhere on the same page. We therefore treat $117 and $198 as advertised promotional numbers, not verified checkout prices.

Look at the tirzepatide rows. At the standard month-to-month prices, $198 is $161 less than $359 — a $1,932 difference over 12 months. But the pricing page also used $198 for promotional weight-loss tirzepatide and rendered $389 next to an annual-plan label. Price alone no longer tells you which path you picked or what term applies.

There is another term problem hiding inside the low prices:

• $150 a month for compounded semaglutide is $1,800 for 12 months. Twelve month-to-month payments at $249 total $2,988 — a $1,188 difference.
• $240 a month for compounded tirzepatide is $2,880 for 12 months. Twelve month-to-month payments at $359 total $4,308 — a $1,428 difference.

Those are our calculations from Fridays' displayed rates. Confirm the charge today, full prepaid term, and renewal price before you submit the intake.

The right GLP-1 provider isn't the same for everyone — it depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred treatment path, and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose. → Get my personalized GLP-1 path

The RX Index is an independent GLP-1 decision resource that scores telehealth providers and treatment paths on clinical legitimacy, care quality, transparency, access, and cost, so readers can choose the path that fits their situation.

Fridays is probably a fit if you:

• Are paying cash and want the compounded medicine, provider visits, dietitian visits, coaching, and fitness support bundled into one displayed price
• Understand that a compounded medicine is not the same as an FDA-approved one
• Can stay on treatment for several months, not several weeks
• Are willing to spend five minutes confirming the exact path, charge today, full term, and renewal price before you pay

Fridays is probably not your best move if you:

• Want an FDA-approved medicine and have not compared your insurance and full cash-pay options yet
• Have insurance that might cover Wegovy or Zepbound and haven't checked yet
• Need a money-back guarantee if you don't lose weight — Fridays doesn't offer one
• Were about to buy a $198 path without confirming which one it is

What we actually verified

We are not Fridays patients. We didn't take the medicine, and we didn't fake a medical intake. Here's exactly what we checked and when:

Checked on August 29, 2026: all eight paths and displayed prices · the exact wording Fridays uses to describe each path · the fine print under its 96.8% badge · its two published member weight-loss numbers and the disclaimer attached to them · its published cancellation and refund terms · its listed pharmacy partners · FDA guidance on compounded GLP-1 drugs · the published trial results for FDA-approved medicines · Trustpilot, BBB, and ConsumerAffairs on the same day · Ro's current pricing and coverage rules.

What we could not verify: the final checkout total behind Fridays' lowest advertised prices, how the $279 and $389 annual-plan labels relate to the lower annual rates elsewhere on the page, the exact active ingredients and per-dose strength of the oral microdose product, which pharmacy fills any individual order, and whether every state on the intake list is currently active. We'll say so again where it matters.

Wait — two Fridays paths aren't for weight loss?

Correct. Fridays sells two microdose GLP-1 paths — a $198/month weekly tirzepatide injection and a $249/month daily oral semaglutide product. If weight loss is your goal, these are not the paths to buy by mistake.

Let's slow down here, because this is the single most useful thing on this page.

Fridays has four tabs across the top of its site: Weight Loss, Microdosing, Longevity, and Testosterone. The weight-loss plans live under one tab. The microdose plans live under a different one. If you land on the microdosing page from an ad or a search, you may never see the weight-loss page at all.

Here is what Fridays itself writes on that microdosing page, word for word:

• Both microdose products are for people "seeking clinician-guided longevity support without a weight loss focus."
• Microdosing uses "lower, subtherapeutic doses."
• "Compounded microdose formulations have not been specifically studied for these outcomes."

What "subtherapeutic" actually means

It's a big word for a simple idea. Therapeutic means "enough to treat something." Sub means "under."

So subtherapeutic means: a dose deliberately set below the level used to treat a condition.

That's not a scandal. It's a real product category, and Fridays is being straight about it. Fridays markets these paths for maintenance, appetite awareness, energy, focus, and general wellness support. But its own FAQ says the compounded formulations have not been studied for those promoted outcomes.

But if you're 40 pounds into a goal and you pick the $198 plan because it looks like the cheapest tirzepatide on the site, you bought the wrong thing. And now that the weight-loss pricing page can also show $198, the risk is not just cheap versus expensive. It is two different paths wearing the same price.

One more thing worth knowing

The microdosing page's current search description says microdosed GLP-1 plans support weight loss.

The product cards on that same page say weight loss is not the focus.

Both statements are tied to the same page. They point in opposite directions. We're not accusing anyone of anything; marketing pages get built by different people at different times. But it explains how a reasonable shopper ends up confused, and it's why we're putting all eight paths in one table instead of trusting any single page to tell you.

The oral card has a second clarity problem. It calls the product compounded microdose semaglutide, describes semaglutide as GLP-1/GIP in one line, then calls it GLP-1 in the next. Semaglutide is a GLP-1 receptor agonist, not a dual GIP/GLP-1 medicine. The card also mentions 10 mg without making clear whether that is per tablet, the total formulation amount, or whether another active ingredient is included.

Before you pay Fridays anything, send its support team two sentences: "Am I enrolling in the weight-loss path or the microdose path? What exact active ingredients, strength, dose form, pharmacy, charge today, and renewal price will apply?" Save the answer. That's it. That's the whole safeguard.

Is Fridays GLP-1 real medicine?

Yes. Fridays connects eligible patients to third-party licensed clinicians through OpenLoop Healthcare Partners, PC and other clinical networks, and coordinates fulfillment through partner pharmacies. Fridays is not the doctor and not the pharmacy — it's the platform that coordinates both. Its compounded products are prescription drugs, but they are not FDA-approved and the FDA has not reviewed the finished compounded products for safety, effectiveness, or quality.

A lot of people arrive at this question because the price gap makes them suspicious. Brand-name Zepbound runs over $1,800 a month on Fridays' own site. Compounded tirzepatide runs $359. That's a five-times difference, and it sets off alarms.

The gap is real, and it has a boring explanation. You're not buying the same finished product.

Who does what

That last row isn't filler. Fridays lists several partner pharmacies. A partner list tells you who might fill your order. Only the label tells you who did.

Compounded vs. FDA-approved: the honest version

A compounded medicine is one a licensed pharmacist, physician, or outsourcing facility prepares under the rules that apply to that compounder. An FDA-approved medicine is a finished product the FDA reviewed and approved before it could be sold.

We're not going to blur these together, because the difference is the whole ballgame:

The FDA has warned marketers not to imply that compounded GLP-1 products are the same as, generic versions of, or clinically proven equivalents to FDA-approved products. We won't describe them that way, and you should be skeptical of any site that does.

The FDA's current advice is stricter than "cheaper is fine": compounded drugs should be used only when a patient's medical needs cannot be met by an FDA-approved drug. A licensed clinician decides whether that applies to you.

Where things stand right now: on April 30, 2026, the FDA proposed not adding semaglutide, tirzepatide, and liraglutide to the 503B bulks list for outsourcing facilities. The public comment deadline was extended to July 30, 2026. We found no final FDA determination in the records checked on August 29, 2026. Traditional 503A compounding follows separate patient-specific rules, including limits on making products that are essentially copies of commercially available drugs. For the full breakdown, see our guide on Fridays' pharmacy partners.

The RX Index Score: how Fridays lands on our five pillars

Does Fridays' GLP-1 actually cause weight loss?

Wegovy and Zepbound — the FDA-approved weight-management medicines on Fridays' site — produced substantial weight loss in product-specific clinical trials. The 14.9% semaglutide number below comes from the injected regimen, not the Wegovy pill. Those trials did not test a Fridays compounded vial. We found no published clinical trial of Fridays' finished compounded products, and Fridays does not cite one. What Fridays can show is its own internal member data, its delivery performance, and thousands of customer reviews. Those are real forms of evidence, and they are not the same thing as trial evidence.

Here's where most pages on this topic go wrong. They say "GLP-1s work" — true for approved products with strong evidence — and then quietly let you assume that proves every Fridays product works the same way. Those are two different claims.

"Works" means five different things

Before you can answer the question, you have to pick which question you're asking:

Fridays scores differently on each one. Most reviews blur all five together into a star rating. Here's the honest breakdown.

What each piece of evidence actually proves

Read that table twice. It's the whole page in one screen.

The one thing we won't sugarcoat

We found no published clinical trial on Fridays' finished compounded products. Every branded trial number you'll see quoted on any site — including this one — belongs to the exact product and regimen that was studied. It is a benchmark, not a promise for a compounded fill.

If a medicine that's been studied as an exact product is what you need, then an FDA-approved path is genuinely the better lane for you, and we'd rather send you there than watch you buy something that doesn't match what you want. Fridays now lists Wegovy pill, Wegovy pen, Zepbound, and Ozempic paths. Ro also carries FDA-approved options and offers insurance support and prior-authorization help.

But here's why plenty of people still choose Fridays with their eyes open. Skipping the brand-name product is exactly why Fridays can display $249 a month with the compounded semaglutide, unlimited provider visits, a dietitian, coaching, and the fitness app all included — instead of a membership fee plus a separate drug bill.

And in the real world, affordability matters. A 2025 real-world study found cost or insurance problems were the most common documented reason people in that health system stopped semaglutide or tirzepatide for obesity.

A plan you can afford to continue beats a plan you abandon for cost.

### Pick your lane — both are honest choices If FDA-approved matters most to you: Ro's membership is $39 for the first month, then as low as $74/month with an annual plan paid upfront, or $149/month if you stay monthly. Medicine is billed separately. The Wegovy pill starts at $149/month for new patients on lower doses, and higher doses cost more. Ro's free insurance checker covers the Ozempic pen, Wegovy pen, and Zepbound pen. → See FDA-approved options and check coverage on Ro (sponsored link) One limit worth knowing: Ro says Medicare, Medicare Advantage, and TRICARE members may use certain cash-pay options. Medicaid and VA members are not eligible for Ro Body at this time. Coverage rules can change. If the all-in compounded price and included support matter more: you now know which Fridays path is the weight-loss path and which isn't. That's the hard part. → See if you qualify for the Fridays weight-loss program (sponsored link · a licensed provider decides if a prescription is appropriate)

What does Fridays' 96.8% success rate actually mean?

It is not a weight-loss statistic. Fridays defines the figure as recent internal fulfillment and delivery performance for paid orders. In plain terms: it measures whether paid orders were filled and delivered, not whether people lost weight.

This number shows up big and bold. The explanation shows up small and gray. Here's both, side by side:

Is that useful? Honestly, yes. Shipping reliability matters a lot with these medicines. A treatment interruption can require a clinician to decide whether you can resume the same dose or should restart lower.

But it is not proof the medicine works. It's proof the order system worked under Fridays' internal measure. Don't let a delivery number do a doctor's job.

How much weight do people actually lose on Fridays?

Fridays publishes two internal numbers: an average of 9.75 pounds lost in the first month among members who started above 175 pounds, and an average 15.28% body-weight reduction at 12 months among members with a documented 12-month weigh-in. Fridays attaches its own limit to both — the results span a range of different prescribed medications and are not tied to a single formulation or brand.

Those numbers are worth taking seriously. They're also worth reading carefully.

What Fridays discloses

Group one — first month: members whose first visit was on or after March 1, 2024, starting above 175 pounds. Average loss in month one: 9.75 pounds.

Group two — 12 months: same starting criteria, plus a recorded weight at the 12-month mark. Average body-weight reduction: 15.28%, current as of April 2025.

What isn't published

We looked for these and didn't find them in Fridays' disclosure:

• How many people were in each group
• How many members started but had no 12-month weigh-in
• Which medicines, formulations, and doses those members were on
• Which pharmacies filled them
• How many stopped because of side effects, cost, or lack of results
• How missing weights were handled
• Any comparison group
• Any outside audit of the analysis

The missing denominator is the biggest hole. A percentage without the number of people who started, stayed, and reported a 12-month weight cannot tell you the program's full completion or response rate.

None of that makes the numbers fake. It makes them internal marketing data, not a study. Both things can be true.

And here's the part that matters most for you personally: an average hides the range. Some people lose more. Some lose less. Some stop. Yours will be your own.

What do real Fridays customers say?

Customer feedback splits sharply by platform. Trustpilot shows 4.2 out of 5 from 4,652 reviews. ConsumerAffairs shows 1.3 out of 5 from 27 reviews. The Better Business Bureau currently displays an F rating for Thrive Health Group Inc., tied to 50 complaints and failure to respond to 44 of them. These measure different things with different samples and should never be averaged into one score.

Averaging a 4.2 and a 1.3 gets you a meaningless number. What the split actually tells you is this: Trustpilot is mostly positive, while ConsumerAffairs and BBB show a much rougher billing-and-support picture. That's a real split, and it should factor into your decision.

There is one detail that cuts against the idea that Fridays ignores every negative public review: Trustpilot says the company replied to 100% of negative reviews on that platform, usually within one week. That does not erase the BBB record. It shows why each platform has to be read for what it actually measures.

Three real service comments

Fridays labels the testimonials on its own pricing page as paid, so we didn't use those. These short comments are from Trustpilot:

"most bang for your buck… consistent care." — Lynnda S., June 5, 2026

"Trying to speak to someone is impossible." — Barbara Sharp, August 27, 2026

"my provider quickly addressed my concerns" — Victoria, August 27, 2026

We picked service comments on purpose. We did not include weight-loss testimonials, and there are plenty of them. A weight-loss testimonial for a compounded medicine is an efficacy claim wearing a customer's face, and we're not going to use one to sell you something. Ratings and review counts move constantly — check them yourself before you decide.

How long does Fridays GLP-1 take to work?

Fridays says most people notice less appetite and fewer cravings within the first few weeks, with visible weight loss usually starting after one or two months of steady use. That is provider guidance, not a promise. The exact timeline depends on the medicine, whether you are on the weight-loss or microdose path, the dose-step plan, side effects, adherence, and your own response.

This is the question we get most from people who already started. So let's be specific.

"It's been six weeks and nothing is happening."

If that's you, take a breath. You are not broken, and six quiet weeks alone do not prove you got scammed.

Three things to check:

1. You're still on a starter dose. These medicines are designed to start low. The starting dose is mainly about letting your body adjust. Many people feel very little until a later step.

2. Your appetite changed and you didn't notice. Ask yourself a different question: are you thinking about food less? Finishing meals less often? That can show up before the scale does.

3. You had a gap in doses. This is the big one, and it's the most fixable.

A shipping delay, a billing hiccup, or a missed refill can put a gap in your treatment. But a gap does not have one automatic outcome. The current Wegovy label says that after two or more missed weekly doses, a patient may resume as scheduled or may need to restart the escalation schedule to reduce stomach side effects.

So a shipping delay can cost more than the days on the calendar, but it does not automatically reset your dose. The right move depends on the medicine, how many doses you missed, your current dose, and the clinician's judgment.

What to do: message your provider through the app. Don't guess, don't double up, and don't change your dose on your own. That's what unlimited provider visits are for — actually use them.

If you're not sure your current plan is even the right one, that's a different problem with a different fix:

→ Get your personalized GLP-1 path — free, about 60 seconds

Which Fridays GLP-1 path should you actually choose?

Match the path to your goal, not to the price. If you want a compounded path built for weight loss, Fridays points to compounded semaglutide or compounded tirzepatide. If you want an FDA-approved weight-management medicine, its current pricing page lists Wegovy pill, Wegovy pen, and Zepbound. Ozempic is FDA-approved for type 2 diabetes and may be used off-label for weight. The microdose paths are marketed for maintenance or wellness, not primary weight loss.

Here's the router. Find your row.

If you're tempted by the $198 path, read this once more

We understand the pull. At the standard month-to-month rates, the microdose tirzepatide path is $161 less than the weight-loss tirzepatide path. That's $1,932 a year.

But the company selling the microdose path says it is not built around a primary weight-loss goal and does not point to product-specific studies for the promoted outcomes. Saving $161 on a path that isn't built for your goal isn't saving money. It's paying $198 a month for the wrong thing.

And now there is a second trap: the current pricing page can also show $198 for promotional weight-loss tirzepatide.

If $359 is out of reach and you still want a compounded weight-loss path, the honest move is to compare the $249 compounded semaglutide path — not to guess which $198 path you found.

You now know exactly what to ask for. That's the part most people get wrong. A licensed provider still decides whether any prescription is right for you. A prescription and a weight-loss result are not guaranteed. → See if you qualify for the Fridays weight-loss program (sponsored link · a licensed provider decides if a prescription is appropriate) Before you pay, confirm one thing in writing: "Is this the weight-loss path or the microdose path, and what will I be charged today and at renewal?"

Does Fridays take insurance, and is it available in every state?

The standard Fridays compounded weight-loss paths are cash-pay bundles. The FDA-approved brand paths use a different setup: the displayed membership price does not include the medicine, and the final drug cost can depend on insurance, prior authorization, dose, and the cash-pay option available to you. Fridays also says its services are not available in every state.

That gives you two checks to finish before you pay:

We did not find a dependable public state-by-state list that we could verify without entering the intake. Use the live eligibility flow, but do not treat reaching the payment screen as proof that a prescription, a specific medicine, or insurance coverage is guaranteed.

If insurance might cover a brand medicine, check that first. If you are paying cash and want the medicine bundled into the displayed program price, compare the two Fridays weight-loss paths — not the microdose cards.

→ Compare your state, coverage, treatment type, and budget

What if it doesn't work — can you get your money back?

Fridays does not offer a weight-loss guarantee. Its published terms state that ordinary fees are non-refundable when a member does not achieve the desired result, and that medicine already dispensed or shipped generally cannot be returned or refunded. To stop your next charge, Fridays requires a cancellation request at least 72 hours before your renewal date.

We're putting this section here, before you click anything, on purpose. It's the question people ask last and should ask first.

Verified from Fridays' terms last updated March 23, 2026 and rechecked August 29, 2026.

One more thing to know before you sign up: Fridays' terms describe billing starting when you submit your medical intake for provider review — not after a prescription is approved. Payment does not guarantee a prescription. If a provider decides treatment isn't appropriate for you before services begin, the terms describe a refund for that cycle. Save every confirmation email and timestamp anyway.

The same terms contain a binding arbitration provision and class-action waiver. That has nothing to do with whether the medicine works, but it changes how legal disputes may be handled.

Do this on day one: put your cancel-by date in your phone calendar the moment you sign up. Set it for four days before your renewal, not three. That one calendar entry gives you a one-day buffer if support does not see a last-minute message.

For the complete fee and billing breakdown, see our guide on Fridays' membership fees and charges.

Is Fridays GLP-1 safe? What could go wrong?

The realistic risks are both medical and practical: stomach side effects, a product that arrives warm or damaged, a treatment gap, an unclear label, and dosing confusion. The FDA has specifically warned about dosing errors with compounded injectable GLP-1 products, including errors that led some patients to seek medical care or be hospitalized.

Side effects, plainly

Nausea, diarrhea, vomiting, constipation, and stomach pain are common with FDA-approved semaglutide and tirzepatide products. Serious problems are less common but real.

The current Wegovy and Zepbound labels say not to use them in people with a personal or family history of medullary thyroid carcinoma or MEN 2. A history of pancreatitis, gallbladder trouble, severe stomach-emptying problems, kidney problems, diabetes medicines, pregnancy plans, or prior serious drug reactions belongs on the intake form and in the clinician conversation.

Tell the provider everything, including supplements. This is a medical decision, and the few minutes you spend on the intake form is where it starts.

Get urgent medical help for trouble breathing, swelling of the face or throat, fainting, or severe and lasting stomach pain. Contact your clinician promptly if vomiting keeps you from holding down fluids or you think you are becoming dehydrated.

The dosing-error warning

This one is specific to compounded medicines, and it's worth 30 seconds of your attention.

FDA-approved products come in labeled, standardized strengths and device instructions. Wegovy injection uses single-dose pens. Zepbound is available in more than one presentation, including single-dose pens and a four-dose KwikPen. Ozempic uses a multi-dose pen. A compounded product may arrive in a vial that requires you to measure liquid with a syringe, and the concentration or syringe markings can differ from a previous fill.

The FDA has received reports of patients and clinicians confusing milligrams, milliliters, and syringe units. Some reports involved doses beyond the approved label schedule.

Before your first dose, do this: read the label out loud. Confirm the active ingredient, concentration, exact amount to draw, syringe marking, route, schedule, storage instructions, and pharmacy. If anything doesn't match what your provider told you, message the provider or dispensing pharmacy before you inject. Not after.

We are not going to give you dose math on this page, and you should be suspicious of any website that does.

The latest FDA numbers — and what they do not mean

As of May 31, 2026, the FDA had received 990 adverse-event reports associated with compounded semaglutide and more than 730 associated with compounded tirzepatide nationwide.

Those are not Fridays-specific numbers. They do not prove the drug caused every event, and the FDA says causation cannot always be determined. The FDA also says the reports are likely incomplete because many traditional state-licensed pharmacies are not required to report adverse events to the agency.

That is the honest reading: not a Fridays accusation, not a reason to panic, and not a number to hide.

Warm, damaged, or wrong shipments

The FDA says injectable GLP-1 products that arrive warm or without enough refrigeration may have a quality problem and should not be used until the issue is resolved. Fridays' terms require damaged or incorrect shipments to be reported within 24 hours.

Take photos of the package, ice packs, label, product, and delivery time. Contact the pharmacy and Fridays before using it.

Supply gaps

Covered above, but it belongs on this list. Shipping delays are a repeated complaint theme, and a gap may change what a clinician tells you to do next. Reorder early. Don't wait until you're on your last dose. If a gap happens, ask the prescriber before taking the next dose.

Who Fridays is right for — and who should skip it

Fridays fits a cash-paying adult who wants a bundled compounded program with medicine, provider access, dietitian support, and coaching, and who understands the product and refund limits. It does not fit someone who needs an FDA-reviewed finished product, has unchecked insurance coverage, needs a results guarantee, or is not ready to confirm the exact path and payment term in writing.

Before you click, five quick yeses

Read these and answer honestly. If any one is a no, don't sign up today.

1. I know whether I'm buying the weight-loss path or the microdose path.
2. I know the exact medicine or formulation, what I'll be charged today, the full term, and the renewal price.
3. I understand a prescription is not guaranteed, compounded products are not FDA-approved, and results are not guaranteed.
4. I know my renewal date and my cancel-by date.
5. I'll check the active ingredients, strength, directions, storage condition, and pharmacy before my first dose.

Five yeses don't guarantee you'll lose weight. They do mean you're deciding with your eyes open — which, for a medical decision you're paying for out of pocket, is the whole job.

### If that's you, here's the next step A licensed provider reviews your history and decides whether treatment is appropriate. Nothing is prescribed automatically. → Check your eligibility for the Fridays weight-loss program (sponsored link) Not your fit? That's a fine outcome, and we'd rather you know now:

• Want FDA-approved with insurance help → see Ro's FDA-approved options (sponsored)
• Want to compare semaglutide specifically → our Fridays semaglutide evidence review
• Want to compare tirzepatide specifically → our Fridays tirzepatide evidence review
• Not sure which medicine or provider fits → Find My GLP-1 Path

How we checked this

We are not Fridays patients. We did not take the medicine, submit a false medical intake, or test a vial.

What we did: loaded Fridays' weight-loss, pricing, and microdosing pages on August 29, 2026, and recorded all eight distinct GLP-1 paths, displayed prices, payment terms, and wording used to describe each one. Read the fine print behind the 96.8% badge and the two member weight-loss figures. Read Fridays' published cancellation and refund terms and its listed pharmacy partners. Checked FDA guidance on compounded GLP-1 medicines and the current status of the FDA's 503B bulks-list proposal. Pulled the published results for FDA-approved medicines from the trial record and FDA materials. Checked Trustpilot, BBB, and ConsumerAffairs on the same day. Checked Ro's current pricing, medicine exclusions, insurance checker, and government-plan rules.

What we could not verify: the final checkout total behind Fridays' lowest advertised prices, the exact formulation of the oral microdose product, which pharmacy fills any individual order, which states are active today, and whether the included support feels useful in practice.

Why this page exists: because "does Fridays GLP-1 work" is really five questions stacked on top of each other, and no single number — not a trial result, not a 96.8% badge, not a star rating — answers all five. We separated them so you can see which evidence applies to what.

Primary sources checked

• Fridays weight-loss page
• Fridays pricing page
• Fridays microdosing page
• Fridays terms and refund rules
• FDA concerns with unapproved GLP-1 drugs
• FDA compounding policy after the shortage
• Federal Register extension for the 503B proposal
• STEP 1 semaglutide trial record
• FDA Zepbound approval summary
• Current FDA Wegovy prescribing information
• Current FDA Zepbound prescribing information
• Real-world GLP-1 discontinuation study
• Trustpilot Fridays profile
• ConsumerAffairs Fridays profile
• BBB Thrive Health Group Inc. profile
• Ro weight-loss pricing
• Ro GLP-1 insurance checker

This page compares public evidence, program terms, and provider-stated information. It is not personal medical advice. A licensed clinician must decide whether a prescription and a specific product are appropriate for you.